As of Nov 25
| +0.16 / +6.45%|
The 5 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a +127.27% increase from the last price of 2.64.
The current consensus among 5 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.